reboxetine has been researched along with Anxiety in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ciucci, MR; Hoffmeister, JD; Kelm-Nelson, CA | 1 |
| Chiu, GS; Freund, GG; Gainey, SJ; Kaczmarczyk, MM; Kelley, KW; Kwakwa, KA; Lawson, MA; Machaj, AS; Martin, SA; Meling, DD; Miller, MJ; Newman, AF; Wang, Y; Woods, JA; York, JM | 1 |
| Berezniuk, I; Biswas, R; Creson, TK; Fricker, AD; Fricker, LD; Rodriguiz, RM; Wetsel, WC; Wilkins, JJ | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Lapmanee, S | 1 |
| Cao, YJ; Hendrix, CW; Kaplin, AI; Rahn, KA | 1 |
| Cowen, PJ; Harmer, CJ; Lester, KJ; Murphy, SE; Yiend, J | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S | 1 |
| Mendels, J; Schwartz, GE; Stahl, SM | 1 |
| Akgoz, S; Akkaya, C; Eker, SS; Kirli, S; Sivrioglu, EY | 1 |
| Bitsios, P; Bradshaw, CM; Phillips, MA; Szabadi, E | 1 |
| Ferguson, JM; Mendels, J; Schwart, GE | 1 |
1 review(s) available for reboxetine and Anxiety
| Article | Year |
|---|---|
Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials.
Topics: Adult; Antidepressive Agents; Anxiety; Confidence Intervals; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morpholines; Psychomotor Agitation; Randomized Controlled Trials as Topic; Reboxetine; Sleep Initiation and Maintenance Disorders | 2002 |
4 trial(s) available for reboxetine and Anxiety
| Article | Year |
|---|---|
Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.
Topics: Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Anxiety; Attention; Citalopram; Decision Making; Double-Blind Method; Female; Humans; Male; Morpholines; Neuropsychological Tests; Reaction Time; Reboxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Young Adult | 2009 |
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Anxiety; Cross-Over Studies; Double-Blind Method; Fluvoxamine; Happiness; Humans; Male; Morpholines; Psychiatric Status Rating Scales; Pupil; Reboxetine; Wakefulness | 2000 |
Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Sleep Initiation and Maintenance Disorders | 2002 |
6 other study(ies) available for reboxetine and Anxiety
| Article | Year |
|---|---|
Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Atomoxetine Hydrochloride; Disease Models, Animal; Humans; Male; Norepinephrine; Parkinson Disease; Protein Kinases; Rats; Rats, Long-Evans; Reboxetine; Vocalization, Animal | 2022 |
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Anxiety; Blood Glucose; Body Weight; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cerebral Cortex; Cytokines; Desipramine; Dietary Fats; Dopamine; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Indoleamine-Pyrrole 2,3,-Dioxygenase; Learning Disabilities; Male; Maze Learning; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Monoamine Oxidase; Morpholines; Motor Activity; Overnutrition; Physical Endurance; Reboxetine; Receptors, Interleukin-1 Type I; Recognition, Psychology | 2013 |
Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) mice.
Topics: Age Factors; Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Carboxypeptidase H; Depression; Diazepam; Exploratory Behavior; Hindlimb Suspension; Maze Learning; Mice; Mice, Transgenic; Morpholines; Motor Activity; Obesity; Point Mutation; Reboxetine; Swimming | 2013 |
Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanols; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Male; Maze Learning; Morpholines; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Running; Stress, Psychological; Sucrose; Swimming; Venlafaxine Hydrochloride | 2013 |
The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Child; Depressive Disorder, Major; Fluoxetine; Humans; Mice; Morpholines; Piperazines; Pyridines; Reboxetine; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Suicidal Ideation; Suicide | 2015 |
Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cyclohexanols; Male; Morpholines; Motor Activity; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Stress, Physiological; Stress, Psychological; Swimming; Venlafaxine Hydrochloride | 2012 |